Search
TriSalus Life Sciences Inc
TLSIAdd to Watchlist
5.100USD
+0.200+4.08%
Close 09-18 16:00（ET）
310.73MMarket Cap
LossP/E TTM
TriSalus Life Sciences Inc (TLSI) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to TriSalus Life Sciences Inc in the past month.
Buy
0 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
9.000USD+88.28%
TLSI Analyst Recommendation Trends
In the current month, TLSI has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TLSI average Analyst price target in the last month is 9.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
1
1
5
4
4
5
5
5
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
4
4
5
5
5
7
7
TLSI Analyst Rating for Peer Comparison
Updated: Sep 18, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, TLSI EPS is projected to reach -0.124 in FY2026Q3, following reported EPS of -0.158 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.13
-0.16
-0.15
-0.12
-0.07
Actual
-0.21
0.03
-0.16
--
--
Surprise
-57.55%
+119.14%
-1.67%
--
--
FAQs
What is TriSalus Life Sciences Inc's expected revenue for the next quarter?
TriSalus Life Sciences Inc's expected revenue is 14.32M.
What is TriSalus Life Sciences Inc's price target?
Analysts forecast that TriSalus Life Sciences Inc's price target is USD 9.00, with the highest forecast at USD 11.00 and the lowest forecast at USD 7.00.
How have TriSalus Life Sciences IncTLSI's recent earnings per share performed?
The market expectation was USD -0.16, while TriSalus Life Sciences IncTLSI's earnings per share (EPS) for the previous quarter was USD 0.03. EPS for the next quarter is expected at USD -0.12.
What is the analyst rating for TriSalus Life Sciences Inc?
Based on the ratings of TriSalus Life Sciences Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.